Series B - Affinivax
Investment Firm
Overview
Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.
Announced Date
Apr 23, 2020
Funding Type
Series B
Highlights
Location
United States, North America
Social
Participant Investors
2
| Investor Name |
|---|
 Viking Global Investors |
Round Details and Background
Affinivax raised $120000000 on 2020-04-23 in Series B
Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jan 08, 2021 |  Series C - Affinivax | 13 | - | 226.0M |
| Mar 09, 2021 | Grant - Affinivax | 1 | - | 22.0M |
| Jan 05, 2018 | Venture Round - Affinivax | - | 7.0M | |
| Feb 05, 2016 | Series A - Affinivax | 1 | - | 2.5M |
Recent Activity
There is no recent news or activity for this profile.